Page last updated: 2024-11-04

vorinostat and Anaplastic Ependymoma

vorinostat has been researched along with Anaplastic Ependymoma in 2 studies

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Gorsi, HS1
Toll, SA1
Sood, S1
Miler, S1
Altinok, D1
Kumar-Sinha, C1
Mody, R1
Yankelevich, M1
Milde, T1
Kleber, S1
Korshunov, A1
Witt, H1
Hielscher, T1
Koch, P1
Kopp, HG1
Jugold, M1
Deubzer, HE1
Oehme, I1
Lodrini, M1
Gröne, HJ1
Benner, A1
Brüstle, O1
Gilbertson, RJ1
von Deimling, A1
Kulozik, AE1
Pfister, SM1
Martin-Villalba, A1
Witt, O1

Other Studies

2 other studies available for vorinostat and Anaplastic Ependymoma

ArticleYear
Ongoing Response in a Multiply Relapsed Metastatic Posterior Fossa Ependymoma A After Vorinostat and Concomitant Irradiation.
    Journal of pediatric hematology/oncology, 2022, Mar-01, Volume: 44, Issue:2

    Topics: Child, Preschool; Combined Modality Therapy; Ependymoma; Histone Deacetylase Inhibitors; Humans; Mal

2022
A novel human high-risk ependymoma stem cell model reveals the differentiation-inducing potential of the histone deacetylase inhibitor Vorinostat.
    Acta neuropathologica, 2011, Volume: 122, Issue:5

    Topics: Animals; Cell Differentiation; Cell Line, Tumor; Ependymoma; Gene Expression Profiling; Histone Deac

2011